01-06-2013 | Letter to the Editor
Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer
Published in: International Journal of Colorectal Disease | Issue 6/2013
Login to get access